Director of Program Management
Rezo Therapeutics
Director of Program Management
Rezo Therapeutics
Maps disease networks to precision therapies
Maps disease networks to precision therapies
Rezo Therapeutics maps disease networks to develop precision medicines using its SSD platform, which integrates proteomics, genetics, structural biology, chemistry, and bioinformatics to build networks of molecular interactions in diseases. The platform analyzes protein‑protein and genetic interactions to identify druggable targets that traditional target‑driven methods might miss, with an initial focus on solid tumor oncology and partnerships for other areas. It differentiates itself by combining high‑level biology with computational network biology in one platform to map whole disease networks rather than chasing single targets, supported by leadership rooted in UCSF’s QBI. The company aims to translate network discoveries into targeted therapies and grow its pipeline through collaborations and strategic partnerships.
Explore more opportunities at Rezo Therapeutics